Dexamethasone-induced catatonia in a patient with multiple myeloma

Acta Clin Belg. 2016 Dec;71(6):438-440. doi: 10.1080/17843286.2016.1146442. Epub 2016 Apr 28.

Abstract

Catatonia is a complex neuropsychiatric syndrome, caused by different underlying metabolic, neurologic, psychiatric and toxic conditions. Although catatonia is often associated with psychiatric disorders such as schizophrenia or depression, in about 20 to 39% of the patients a somatic illness is found. Unfortunately, this diagnosis is often missed although catatonia is characterized by a specific symptom complex. We report a case of acute catatonia with psychotic features in a patient with multiple myeloma (MM), caused by systemic use of dexamethasone. Physicians should be aware of possible psychiatric side effects when prescribing high doses of dexamethasone. Further, MM patients on corticosteroids should be closely monitored for mild psychological and/or psychiatric symptoms since they may be predictive for the onset of catatonia.

Keywords: Catatonia; Corticosteroids; Dexamethasone; Multiple myeloma.

Publication types

  • Case Reports

MeSH terms

  • Catatonia / chemically induced*
  • Catatonia / drug therapy
  • Dexamethasone / adverse effects*
  • Dexamethasone / therapeutic use
  • GABA Modulators / therapeutic use
  • Glucocorticoids / adverse effects
  • Glucocorticoids / therapeutic use
  • Humans
  • Lorazepam / therapeutic use*
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*

Substances

  • GABA Modulators
  • Glucocorticoids
  • Dexamethasone
  • Lorazepam